How DBS works
Parkinson's changes activity in brain networks involved in movement. In DBS, thin leads are placed in carefully selected areas of the brain. A small implanted pulse generator sends electrical stimulation through those leads. A clinician adjusts the settings with a programmer.
You can think of DBS as an adjustable system that changes troublesome movement signals. The stimulation does not destroy brain tissue, and settings can be changed or turned off. That adjustability is one major difference between DBS and procedures that create a permanent lesion.
It is a tool for managing selected symptoms. Parkinson's continues, and follow-up care, medication and exercise may still be part of life.
The three main parts
- Leads: thin insulated wires placed in a specific brain target.
- Extension wires: wires under the skin that connect the brain leads to the pulse generator.
- Pulse generator: a battery-powered device usually placed under the skin near the upper chest.
Systems and procedures differ. Some batteries are rechargeable and some are replaced when depleted. Some systems can sense certain brain signals. Device choices should be made with a DBS team based on your needs, anatomy, local availability and follow-up plan.
Learn which device and center questions are yours to ask →
Which Parkinson's symptoms may improve?
DBS most often helps symptoms that improve when levodopa is working, including tremor, rigidity, slowness and motor fluctuations. It can also reduce dyskinesia for some people. Tremor is an important exception because medication-resistant tremor can sometimes respond to DBS.
Response varies. A good outcome is usually defined around personal goals, such as having more predictable movement time, reducing severe tremor or making daily activities easier.
What DBS may not reliably improve
DBS is generally less reliable for symptoms that never respond to levodopa. Balance, freezing of gait, speech and swallowing can be complicated: they may improve, stay the same or sometimes worsen depending on the person, target, disease stage and settings. DBS is not a treatment for dementia and can create concern when significant thinking or uncontrolled psychiatric problems are present.
Two people with Parkinson's can have very different symptom patterns, goals and risks. Your own levodopa response and multidisciplinary evaluation matter more than a testimonial.
Common brain targets
| Target | Plain-language role |
|---|---|
| STN Subthalamic nucleus | Commonly used for Parkinson's motor symptoms and may allow medication reduction in some people. |
| GPi Globus pallidus internus | Also used for motor fluctuations and dyskinesia; target selection depends on the person's goals and clinical profile. |
| VIM Ventral intermediate nucleus | Primarily used to control tremor rather than the broader set of Parkinson's symptoms. |
Your team chooses a target after considering which symptoms matter most, medication response, thinking and mood, anatomy, risk and clinical experience.